Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEVG.L Regulatory News (EVG)

  • There is currently no data for EVG

Form 8.5 (EPT/RI)

29 Sep 2011 11:25

RNS Number : 1888P
Bank of America Merrill Lynch
29 September 2011
 



FORM 8.5 (EPT/RI)

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH

RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the "Code")

1. KEY INFORMATION

(a) Name of exempt principal trader: Bank of America Merrill Lynch

(b) Name of offeror/offeree in relation to whose Evolution Group Plc

relevant securities this form relates:

(c) Name of the party to the offer with which exempt Advisor to INVESTEC PLC and

INVESTEC LTD

principal trader is connected:

(d) Date dealing undertaken: 28/09/2011

(e) Has the EPT previously disclosed, or is it today NO

disclosing, under the Code in respect of any other

party to this offer?

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

(a) Purchases and sales

Class of Purchase/ Total number Highest price Lowest price

relevant Sales of securities per unit per unit

security paid/received paid/received

Common - GB0030221864 Purchase 10,713 GBP 0.84 GBP 0.83

Common - GB0030221864 Sale 4,769 GBP 0.84 GBP 0.83

(b) Derivatives transactions (other than options)

Class of Product  Nature of dealing Number of  Price per unit

relevant description reference securities

security eg. CFD

Common - GB0030221864 Swap SHORT 3949 GBP 0.83

Common - GB0030221864 Swap SHORT 2877 GBP 0.83

Common - GB0030221864 Swap SHORT 1595 GBP 0.84

Common - GB0030221864 Swap SHORT 1369 GBP 0.83

Common - GB0030221864 Swap SHORT 530 GBP 0.83

Common - GB0030221864 Swap SHORT 378 GBP 0.83

Common - GB0030221864 Swap SHORT 15 GBP 0.83

Class of Product  Nature of dealing Number of  Price per unit

relevant description reference securities

security eg. CFD

Common - GB0030221864 Swap LONG 545 GBP 0.84

Common - GB0030221864 Swap LONG 1369 GBP 0.83

Common - GB0030221864 Swap LONG 2855 GBP 0.83

(c) Options transactions in respect of existing securities

(i) Writing, selling, purchasing or varying

Class of Product Writing, Number of Exercise Type Expiry Option

relevant description purchasing, securities price date money

security selling, to which per unit paid/

varying etc. option received

relates per unit

(ii) Exercising

Class of relevant Product description Number of securities Exercise price per unit

security

(d) Other dealings (including subscribing for new securities)

Class of relevant Nature of dealing Details Price per unit (if

security applicable)

3. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding,

formal or informal, relating to relevant securities which may be an inducement to deal

or refrain from dealing entered into by the exempt principal trader making the

disclosure and any party to the offer or any person acting in concert with a party to the

offer:

NONE

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between

the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which

any derivative is referenced:

NONE

Date of disclosure: 29/09/2011

Contact name: Doug Berwick

Telephone number: +44 20 7995 8859

FORM 8.5 (EPT/RI)

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH

RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the "Code")

1. KEY INFORMATION

(a) Name of exempt principal trader: Bank of America Merrill Lynch

(b) Name of offeror/offeree in relation to whose INVESTEC PLC

relevant securities this form relates:

(c) Name of the party to the offer with which exempt Advisor to INVESTEC PLC and

INVESTEC LTD

principal trader is connected:

(d) Date dealing undertaken: 28/09/2011

(e) Has the EPT previously disclosed, or is it today NO

disclosing, under the Code in respect of any other

party to this offer?

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

(a) Purchases and sales

Class of Purchase/ Total number Highest price Lowest price

relevant Sales of securities per unit per unit

security paid/received paid/received

Common - GB00B17BBQ50 Purchase 15,653 GBP 3.74 GBP 3.69

Common - GB00B17BBQ50 Sale 21,524 GBP 3.75 GBP 3.69

(b) Derivatives transactions (other than options)

Class of Product  Nature of dealing Number of  Price per unit

relevant description reference securities

security eg. CFD

Common - Swap SHORT 2179 GBP 3.74

Common - Swap SHORT 35 GBP 3.74

Common - Swap SHORT 62 GBP 3.74

Common - Swap SHORT 125 GBP 3.74

Common - Swap SHORT 176 GBP 3.73

Common - Swap SHORT 1053 GBP 3.74

Common - Swap SHORT 1086 GBP 3.71

Common - Swap SHORT 1206 GBP 3.71

Common - Swap SHORT 10 GBP 3.74 

Common - Swap SHORT 10 GBP 3.74

Common - Swap SHORT 1836 GBP 3.70

Common - Swap SHORT 2648 GBP 3.73

Common - Swap SHORT 3540 GBP 3.74

Common - Swap SHORT 1409 GBP 3.74

 

Class of Product  Nature of dealing Number of  Price per unit

relevant description reference securities

security eg. CFD

Common - Swap LONG 35 GBP 3.75

Common - Swap LONG 8720 GBP 3.72

Common - Swap LONG 3657 GBP 3.70

Common - Swap LONG 2292 GBP 3.70

Common - Swap LONG 1047 GBP 3.72

Common - Swap LONG 661 GBP 3.74

Common - Swap LONG 62 GBP 3.75

(c) Options transactions in respect of existing securities

(i) Writing, selling, purchasing or varying

Class of Product Writing, Number of Exercise Type Expiry Option

relevant description purchasing, securities price date money

security selling, to which per unit paid/

varying etc. option received

relates per unit

(ii) Exercising

Class of relevant Product description Number of securities Exercise price per unit

security

(d) Other dealings (including subscribing for new securities)

Class of relevant Nature of dealing Details Price per unit (if

security applicable)

 

3. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding,

formal or informal, relating to relevant securities which may be an inducement to deal

or refrain from dealing entered into by the exempt principal trader making the

disclosure and any party to the offer or any person acting in concert with a party to the

offer:

NONE

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between

the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which

any derivative is referenced:

NONE

Date of disclosure: 29/09/2011

Contact name: Balenkosi Dungeni

Telephone number: +44 20 7996 1639

FORM 8.5 (EPT/RI)

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH

RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the "Code")

1. KEY INFORMATION

(a) Name of exempt principal trader: Bank of America Merrill Lynch

(b) Name of offeror/offeree in relation to whose Hansen Transmissions International NV

relevant securities this form relates:

(c) Name of the party to the offer with which exempt Advisor to Hansen Transmissions

International NV

principal trader is connected:

(d) Date dealing undertaken: 28/09/2011

(e) Has the EPT previously disclosed, or is it today NO

disclosing, under the Code in respect of any other

party to this offer?

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

(a) Purchases and sales

Class of Purchase/ Total number Highest price Lowest price

relevant Sales of securities per unit per unit

security paid/received paid/received

Common - BE0947727377 Purchase 196,658 GBP 0.65 GBP 0.65

Common - BE0947727377 Sale 177,759 GBP 0.65 GBP 0.65

(b) Derivatives transactions (other than options)

Class of Product  Nature of dealing Number of  Price per unit

relevant description reference securities

security eg. CFD

Common - BE0947727377 Swap SHORT 12881 GBP 0.65

Common - BE0947727377 Swap SHORT 11225 GBP 0.65

Common - BE0947727377 Swap SHORT 7477 GBP 0.65

Common - BE0947727377 Swap SHORT 6666 GBP 0.65

Common - BE0947727377 Swap SHORT 1034 GBP 0.65

(c) Options transactions in respect of existing securities

(i) Writing, selling, purchasing or varying

Class of Product Writing, Number of Exercise Type Expiry Option

relevant description purchasing, securities price date money

security selling, to which per unit paid/

varying etc. option received

relates per unit

 

(ii) Exercising

Class of relevant Product description Number of securities Exercise price per unit

security

(d) Other dealings (including subscribing for new securities)

Class of relevant Nature of dealing Details Price per unit (if

security applicable)

3. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding,

formal or informal, relating to relevant securities which may be an inducement to deal

or refrain from dealing entered into by the exempt principal trader making the

disclosure and any party to the offer or any person acting in concert with a party to the

offer:

NONE

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between

the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which

any derivative is referenced:

NONE

Date of disclosure: 29/09/2011

Contact name: Doug Berwick

Telephone number: +44 20 7995 8859

FORM 8.5 (EPT/RI)

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH

RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the "Code")

1. KEY INFORMATION

(a) Name of exempt principal trader: Bank of America Merrill Lynch

(b) Name of offeror/offeree in relation to whose Autonomy Corporation Plc

relevant securities this form relates:

(c) Name of the party to the offer with which exempt Advisor to Autonomy Corporation Plc

principal trader is connected:

(d) Date dealing undertaken: 28/09/2011

(e) Has the EPT previously disclosed, or is it today NO

disclosing, under the Code in respect of any other

party to this offer?

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

(a) Purchases and sales

Class of Purchase/ Total number Highest price Lowest price

relevant Sales of securities per unit per unit

security paid/received paid/received

Common - GB0055007982 Purchase 7,972 GBP 25.39 GBP 25.35

Common - GB0055007982 Sale 6,483 GBP 25.38 GBP 25.33

(b) Derivatives transactions (other than options)

Class of Product  Nature of dealing Number of  Price per unit

relevant description reference securities

security eg. CFD

Common - GB0055007982 Swap SHORT 3119 GBP 25.38

Common - GB0055007982 Swap SHORT 800 GBP 25.38

Common - GB0055007982 Swap SHORT 132 GBP 25.35

Class of Product  Nature of dealing Number of  Price per unit

relevant description reference securities

security eg. CFD

Common - GB0055007982 Swap LONG 1 GBP 25.37

Common - GB0055007982 Swap LONG 2 GBP 25.37 

Common - GB0055007982 Swap LONG 2 GBP 25.37

Common - GB0055007982 Swap LONG 2 GBP 25.37

Common - GB0055007982 Swap LONG 3 GBP 25.37

Common - GB0055007982 Swap LONG 5 GBP 25.37

Common - GB0055007982 Swap LONG 20 GBP 25.37

Common - GB0055007982 Swap LONG 27 GBP 25.37

Common - GB0055007982 Swap LONG 103 GBP 25.37

Common - GB0055007982 Swap LONG 715 GBP 25.38

Common - GB0055007982 Swap LONG 800 GBP 25.33

Common - GB0055007982 Swap LONG 819 GBP 25.39

Common - GB0055007982 Swap LONG 2354 GBP 25.33

(c) Options transactions in respect of existing securities

(i) Writing, selling, purchasing or varying

Class of Product Writing, Number of Exercise Type Expiry Option

relevant description purchasing, securities price date money

security selling, to which per unit paid/

varying etc. option received

relates per unit

(ii) Exercising

Class of relevant Product description Number of securities Exercise price per unit

security

(d) Other dealings (including subscribing for new securities)

Class of relevant Nature of dealing Details Price per unit (if

security applicable)

3. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding,

formal or informal, relating to relevant securities which may be an inducement to deal

or refrain from dealing entered into by the exempt principal trader making the

disclosure and any party to the offer or any person acting in concert with a party to the

offer:

NONE

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between

the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which

any derivative is referenced:

NONE

Date of disclosure: 29/09/2011

Contact name: Doug Berwick

Telephone number: +44 20 7995 8859

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
FERBKLFLFKFLBBF
Date   Source Headline
28th Mar 20197:00 amRNSPoster presentation of Imperial College data
25th Mar 20197:00 amRNSSFX-01 meets primary endpoints in STEM trial
18th Mar 20192:01 pmRNSPrice Monitoring Extension
18th Mar 20197:00 amRNSUpdate on SFX-01 trial read-out dates
5th Mar 20197:00 amRNSSFX-01 data published in peer reviewed journal
6th Feb 20193:30 pmRNSHolding(s) in Company
5th Feb 20197:00 amRNSClinical trial update confirms read-outs on track
30th Jan 20195:28 pmRNSGrant of Options
23rd Jan 20197:00 amRNSSFX-01 featured in Nature Reviews Drug Discovery
22nd Jan 20197:00 amRNSChange of Adviser
19th Dec 20186:02 pmRNSShare option exercise and issue of equity
12th Dec 20187:00 amRNSInterim Results
10th Dec 20183:00 pmRNSNominated Adviser Status
4th Dec 20187:00 amRNSPoster Presentation of SFX-01 and Trial Update
3rd Dec 20187:00 amRNSNotification of Half Year Results
19th Nov 20187:00 amRNSInvestor Presentation in Manchester
8th Nov 20187:00 amRNSDirectorate Changes
23rd Oct 20189:57 amRNSHolding(s) in Company
18th Oct 20187:00 amRNSPlacing
18th Sep 20187:00 amRNSInvestor Symposium
11th Sep 20187:00 amRNSNotice of Investor Symposium
26th Jul 20183:22 pmRNSResult of AGM
26th Jul 20187:00 amRNSAGM Statement
25th Jul 20187:00 amRNSFinal Patient Recruited in STEM Phase IIa Trial
10th Jul 201811:00 amRNSGrant of share options, issue of equity and TVR
29th Jun 201810:45 amEQSHardman & Co Research: Evgen Pharma (EVG): 2018, a pivotal year
21st Jun 201812:30 pmRNSPosting of Annual Report and AGM Notice
13th Jun 20182:15 pmEQSHardman & Co Research: Evgen Pharma (EVG): Encouraging interim data from the STEM trial
13th Jun 20187:00 amRNSFull Year Results
11th Jun 20189:05 amRNSSecond Price Monitoring Extn
11th Jun 20189:00 amRNSPrice Monitoring Extension
11th Jun 20187:00 amRNSInterim Update on STEM Trial
7th Jun 20184:40 pmRNSSecond Price Monitoring Extn
7th Jun 20184:35 pmRNSPrice Monitoring Extension
30th May 20187:00 amRNSNotification of Preliminary Results
15th May 201811:00 amRNSPrice Monitoring Extension
14th May 20187:00 amRNSUpcoming Investor Presentations
2nd May 20187:00 amRNSGrant of further European patent
26th Apr 20184:40 pmRNSSecond Price Monitoring Extn
26th Apr 20184:35 pmRNSPrice Monitoring Extension
24th Apr 20187:00 amRNSPresentation at World Orphan Drug Congress USA
20th Mar 20187:00 amRNSResearch Collaboration with Imperial College
5th Mar 20187:00 amRNSUpdate on Novel Sulforaphane Analogues
15th Jan 20187:00 amRNSPoster Presentation of SFX-01 Mechanistic Data
10th Jan 20184:31 pmRNSNotification of Major Interest in Shares
5th Jan 20189:49 amRNSNotification of Major Interest in Shares
5th Jan 20189:48 amRNSNotification of Major Interest in Shares
2nd Jan 20185:44 pmRNSTotal Voting Rights
28th Dec 201711:49 amRNSResult of General Meeting
22nd Dec 201710:10 amRNSGrant of Options

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.